Forecasting for the Pharmaceutical Industry : Models for New Product and In-Market Forecasting and How to Use Them by Arthur G. Cook (2015, Hardcover)

notay6012 (168)
100% positive Feedback
Price:
US $50.00
Approximately£36.90
+ $30.51 postage
Estimated delivery Mon, 23 Jun - Tue, 1 Jul
Returns:
30 days return. Buyer pays for return postage. If you use an eBay delivery label, it will be deducted from your refund amount.
Condition:
New
Book is brand new. Comes as is, no returns or exchanges. Continental US buyers only - Alaska, Hawaii, and international buyers please send a message first.

About this product

Product Identifiers

PublisherRoutledge
ISBN-101472460111
ISBN-139781472460110
eBay Product ID (ePID)219606531

Product Key Features

Number of Pages234 Pages
LanguageEnglish
Publication NameForecasting for the Pharmaceutical Industry : Models for New Product and In-Market Forecasting and How to Use Them
SubjectIndustries / Pharmaceutical & Biotechnology
Publication Year2015
TypeTextbook
AuthorArthur G. Cook
Subject AreaBusiness & Economics
FormatHardcover

Dimensions

Item Height0.8 in
Item Weight23.2 Oz
Item Length9.8 in
Item Width7 in

Additional Product Features

Edition Number2
Intended AudienceCollege Audience
LCCN2014-049871
Dewey Edition22
IllustratedYes
Dewey Decimal615.1068/4
Edition DescriptionRevised edition,New Edition
SynopsisThe second edition of Forecasting for the Pharmaceutical Industry continues to be a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making.The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars., Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex 'black box' equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars., Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making.In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex 'black box' equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion.Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge.The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars., Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ¿black box¿ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
LC Classification NumberHD9665.5.C666 2015

All listings for this product

Buy it now
Any condition
New
Pre-owned
No ratings or reviews yet
Be the first to write a review